SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Mahavir Advanced Remedies Ltd (531689)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531689 NSE: Pharmaceuticals & Drugs | Small Cap | IndoAmerican Advance Share Price

BSE Share Price
Not Listed

Mahavir Advanced Remedies Ltd (531689)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531689 NSE: Pharmaceuticals & Drugs | Small Cap | IndoAmerican Advance Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹171 Cr.
Current Price
₹0
52-Week Low / High
₹151 / 151
TTM EPS
₹0.2
TTM Sales
₹0.2 Cr.
Book Value per Share
₹7.9
P/E Ratio
660.72
In line with its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
19.18
In line with its 5-year historical median
Price to Sales (P/S)
838.85
In line with its 5-year historical median
EV/EBITDA
782.70
In line with its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
1.58%
Underperforms industry median
Return on Capital Employed (ROCE)
1.58%
Underperforms industry median
Return on Assets (ROA)
1.58%
Operating Profit Margin
-77%
Net Profit Margin
133.89%
Gross Profit Margin
133.9%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-28.57%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
0.97%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹-2 Cr.
Equity
₹11.4 Cr.
Face Value
₹10
All Time Low / High
₹7.30 / 374.10

Mahavir Advanced Remedies stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Mahavir Advanced Remedies Ltd a good quality company?
Mahavir Advanced Remedies Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Mahavir Advanced Remedies Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Mahavir Advanced Remedies Ltd vs industry peers?
Mahavir Advanced Remedies Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Mahavir Advanced Remedies Ltd?
Promoters hold 0.97% of the Mahavir Advanced Remedies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Mahavir Advanced Remedies Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Mahavir Advanced Remedies Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % ⓘ0%0%0%0%0%-11.4%-6.2%-39.3%-3.3%1.6%-

Growth Parameters ⓘ
Sales ⓘ000000.20.20.20.10.10
Sales YoY Gr.-NANANANANA26.3%-12.5%-33.3%-28.6%-
Adj EPS ⓘ00000-0.1-0.1-0.2-0.10.10.2
YoY Gr.-NANANANANANANANANA-
BVPS (₹) ⓘ000001.52.41.57.67.77.9
Adj Net
Profit ⓘ		00000-0.1-0.1-0.1-0.20.10
Cash Flow from Ops. ⓘ000000-00-8.20.5-
Debt/CF from Ops. ⓘ0000000000-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA-25.3%-28.6%
Adj EPS ⓘNANANANA
BVPSⓘNANA48.6%1.6%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on
Equity % ⓘ		00000-6.7-5-10.1-3.31.63
Op. Profit
Mgn % ⓘ		00000-9.4-3.19.4-118-778.6
Net Profit
Mgn % ⓘ		00000-32.8-19.6-39.2-112.1133.9130.6
Debt to
Equity ⓘ		0000000000-
Working Cap
Days ⓘ		0000005961,11512,46930,0699,856
Cash Conv.
Cycle ⓘ		000000-386761181899,848

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14
Sales00000
Operating Expenses ⓘ + 00100
Manufacturing Costs00000
Material Costs00000
Employee Cost 00000
Other Costs ⓘ 00000
Operating Profit ⓘ -0-0-0-0-0
Operating Profit Margin (%) -9.4%-3.1%-152.0%-118.0%-77.0%
Other Income ⓘ + 00000
Exceptional Items ⓘ 00000
Interest ⓘ 00000
Depreciation ⓘ 00000
Profit Before Tax ⓘ -0-0-0-00
Tax ⓘ 00000
Profit After Tax -0-0-0-00
PAT Margin (%) -32.8%-19.6%-152.0%-112.0%133.9%
Adjusted EPS (₹)-0.2-0.1-0.8-0.10.1
Dividend Payout Ratio (%)0%0%0%0%0%

Valuation of IndoAmerican Advance - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Shareholders Fund + 11199
Share Capital ⓘ 4441111
Reserves ⓘ -3-3-3-3-3
Debt +00000
Long Term Debt00000
Short Term Debt00000
Minority Interest00000
Trade Payables00000
Others Liabilities ⓘ 00000
Total Liabilities ⓘ 11199

Fixed Assets

Net Fixed Assets ⓘ +00000
Gross Block10000
Accumulated Depreciation00000
CWIP ⓘ 00000
Investments ⓘ 00000
Inventories00000
Trade Receivables00000
Cash Equivalents 00000
Others Assets ⓘ 00198
Total Assets ⓘ 11199

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14
Cash Flow From Operating Activity ⓘ + 0-00-80
PBT ⓘ -0-0-0-00
Adjustment ⓘ 00000
Changes in Working Capital ⓘ 0-0-0-80
Tax Paid ⓘ 00000
Cash Flow From Investing Activity ⓘ + 00000
Capex 00000
Net Investments 00-000
Others ⓘ 00000
Cash Flow From Financing Activity ⓘ + 00080
Net Proceeds from Shares ⓘ 000-00
Net Proceeds from Borrowing ⓘ 00000
Interest Paid ⓘ 00000
Dividend Paid ⓘ 00000
Others ⓘ 00080
Net Cash Flow ⓘ 0-00-00

Financial Ratio

PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14
Ratios
ROE (%)-11.46-6.57-43.46-3.321.58
ROCE (%)-11.44-6.24-39.33-3.281.58
Asset Turnover Ratio0.180.230.240.030.01
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A
Working Capital Days
Receivable Days213.70166.20187.10284.900
Inventory Days00000
Payable Days175.100000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Mahavir Advanced Remedies Ltd FAQs

The current trading price of IndoAmerican Advance on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of IndoAmerican Advance stood at ₹171.1 Cr

The latest P/E ratio of IndoAmerican Advance as of 31-Dec-1969 is 660.7.

The latest P/B ratio of IndoAmerican Advance as of 31-Dec-1969 is 19.18.

The 52-week high of IndoAmerican Advance is ₹150.7 and the 52-week low is ₹150.7.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of IndoAmerican Advance is ₹0.20 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Mahavir Advanced Remedies Ltd is a below average quality company.

No data found

No data found

About Mahavir Advanced Remedies Ltd

Indo American Advanced Pharmaceuticals was incorporated on April 29, 1992 was set up to make branded and generic formulations under different systems of medicine such as allopathy, ayurveda and siddha. The company was earlier known as Indo American Advance Pharmaceuticals, it got its present name on December 20, 1996.

The company is located in the Nellore District of Andhra Pradesh, the manufacturing facility was established for manufacturing a variety of formulations including tablets, capsules, liquids and ointments in the field of antibiotics, analgesics, anti-pyretic, antibacterial, anti-inflammatory, and other genres. The company has been suspended from the BSE on account of non-compliance with the listing agreement clauses.

The registered office of the company is located at 24, 2nd Floor, Railway Colony, III Street, NMM Road, Chennai-600029, Tamil Nadu.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×